Fecal microbiota transplantation for the treatment of recurrent <i>Clostridioides difficile</i> (<i>Clostridium difficile</i>)-Reference-Cited by-同舟云学术

Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile)

Published:2023-04-25 Issue:4 Volume:2023 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Minkoff Nathan Zev¹,Aslam Scheherzade²,Medina Melissa³,Tanner-Smith Emily E⁴,Zackular Joseph P⁵,Acra Sari⁶,Nicholson Maribeth R⁶,Imdad Aamer⁷

Affiliation:

1. Pediatric Gastroenterology, Hepatology and Nutrition; Valley Children's Hospital; Madera California USA

2. Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition; University of Nebraska Medical Center; Omaha Nebraska USA

3. Department of Public Health and Preventative Medicine; SUNY Upstate Medical University; Syracuse, New York USA

4. Counseling Psychology and Human Services; University of Oregon; Eugene Oregon USA

5. Department of Pathology and Laboratory Medicine; University of Pennsylvania and Children’s Hospital of Philadelphia; Philadelphia Pennsylvania USA

6. Department of Pediatrics, D. Brent Polk Division of Gastroenterology, Hepatology and Nutrition; Vanderbilt University School of Medicine; Nashville Tennessee USA

7. Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition; SUNY Upstate Medical University; Syracuse New York USA

Publisher

Wiley

Subject

Pharmacology (medical)

Reference128 articles.

1. Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection;Cammarota;Alimentary Pharmacology and Therapeutics,2015

2. Oral vancomycin followed by fecal transplantation versus tapering oral vancomycin treatment for recurrent Clostridium difficile infection: an open-label, randomized controlled trial;Hota;Clinical Infectious Diseases,2017

3. Fecal microbiota transplantation is superior to fidaxomicin for treatment of recurrent Clostridium difficile infection;Hvas;Gastroenterology,2019

4. Effect of fecal microbiota transplantation on recurrence in multiply recurrent Clostridium difficile infection – a randomized trial;Kelly;Annals of Internal Medicine,2016

5. Complete microbiota engraftment is not essential for recovery from recurrent Clostridium difficile infection following fecal microbiota transplantation;Staley;mBio,2016

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutics involved in managing initial and recurrent Clostridium difficile infection: An updated literature review;World Journal of Gastrointestinal Pharmacology and Therapeutics;2024-09-05

2. Lower fecal microbiota transplantation ameliorates ulcerative colitis by eliminating oral-derived Fusobacterium nucleatum and virulence factor;Gut Pathogens;2024-08-08

3. Exploring the Gut Microbiota: Key Insights Into Its Role in Obesity, Metabolic Syndrome, and Type 2 Diabetes;The Journal of Clinical Endocrinology & Metabolism;2024-07-23

4. Evaluation of Bacterial Viability for Fecal Microbiota Transplantation: Impact of Thawing Temperature and Storage Time;Microorganisms;2024-06-25

5. Comparative Efficacy of Fecal Microbiota Transplantation in Treating Refractory or Recurrent Clostridioides difficile Infection among Patients with and without Inflammatory Bowel Disease: A Retrospective Cohort Study;Biomedicines;2024-06-23